ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- (Curia), a leading global contract, development and manufacturing organization (CDMO), today announced a strategic investment to expand its sterile API ...
The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...
Novo is the largest participant in the GLP-1 market. Macquarie put its share at about 51% by volume and 37% by value in the ...
DUBLIN, April 12, 2022 /PRNewswire/ -- The "Pharmaceutical API Manufacturing Global Market Report 2022: By Therapy, By API, By Drug" report has been added to ResearchAndMarkets.com's offering. The ...
Therapiva, a joint venture of Abu Dhabi-based Neopharma and India’s Laxai Life Sciences, says it has a GMP manufacturing plant in India. It will now add Dr. Reddy's entire API manufacturing business. ...
Italy's Olon, a maker of generic drugs and APIs, has acquired an API plant in India. (Eric Palmer) CDMO Olon is continuing its expansion binge with a deal to buy an API plant in India that supplies ...
Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...
ALBANY, N.Y.--(BUSINESS WIRE)--Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced plans to expand its commercial manufacturing capacity at ...
(MENAFN- IMARC Group) An API (Active Pharmaceutical Ingredient) is the biologically active component of a drug that produces the intended therapeutic effect. It is the essential substance in medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results